Blog
RSS FeedPosted by Michael Wonder on 21 Jan 2022
National Medicines Policy Review – publication of submissions
21 January 2022 - On 30 August 2021, the National Medicines Policy Review Committee invited submissions to support the Review of ...
Posted by Michael Wonder on 20 Jan 2022
NICE moves: increased accessibility and flexibility for health tech
19 January 2022 - NICE also aims to make strides in digital, genomic and antimicrobial technologies ...
Posted by Michael Wonder on 19 Jan 2022
UK’s NICE to launch sweeping changes to drug assessments to be faster, more agile
19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...
Posted by Michael Wonder on 19 Jan 2022
Early benefit assessment for new drugs 2021: G-BA sets a record with 146 completed procedures
10 January 2022 - At the beginning of the year, the Federal Joint Committee (G-BA) took stock of its assessment of ...
Posted by Michael Wonder on 18 Jan 2022
TGA in review (2021)
19 January 2022 - Using a liberal definition of what constitutes a 'new medicine', we have determined the TGA approved ...
Posted by Michael Wonder on 11 Jan 2022
FDA approved more first in class drugs, gave more accelerated approvals in 2021
7 January 2022 - The US Food and Drug Administration’s Center for Drug Evaluation and Research approved 50 new drug therapies ...
Posted by Michael Wonder on 20 Dec 2021
PHARMAC’s year in review
20 December 2021 - Today PHARMAC has released its Year in Review for 2021, an annual publication highlighting key aspects of ...
Posted by Michael Wonder on 11 Dec 2021
‘All I want for Christmas’ is higher prices: Congressional report accuses pharma of manipulating Americans for profit
10 December 2021 - It was the day before Christmas in 2015 and a senior director of national accounts at ...
Posted by Michael Wonder on 07 Dec 2021
Shining a light on PHARMAC
6 December 2021 - It is encouraging to read the country’s drug buying agency PHARMAC is already moving to improve ...
Posted by Michael Wonder on 04 Dec 2021
Reforms needed for FDA’s regulation of medical devices
3 December 2021 - Medical devices are mainstays of modern medicine, from basic products like gloves and bandages to complex ...
Posted by Michael Wonder on 02 Dec 2021
PHARMAC review: 'Damning' interim report reveals 'fortress mentality', Māori, equity progress slow
2 December 2021 - An interim report of a major PHARMAC review has slated the Government drug buying agency over ...
Posted by Michael Wonder on 02 Dec 2021
PHARMAC welcomes interim report
2 December 2021 - PHARMAC accepts many of the observations made in the Interim Report and is already making changes ...
Posted by Michael Wonder on 25 Nov 2021
Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology
25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...
Posted by Michael Wonder on 25 Nov 2021
MTAA welcomes new frontiers report
25 November 2021 - The Medical Technology Association of Australia wishes to thank Trent Zimmerman MP and Dr Mike Freelander MP ...
Posted by Michael Wonder on 25 Nov 2021
Medicines Australia welcomes tabling of parliamentary report about approval processes for new drugs and novel medical technologies
25 November 2021 - Medicines Australia welcomes the House of Representatives Health, Aged Care and Sport Committee Inquiry report into ...